生物制药股Dynavax Technologies盘前大涨40%

环球市场播报
Dec 24, 2025

  生物制药股Dynavax Technologies(DVAX)周三盘前大涨40%,此前赛诺菲Sanofi)表示将以约22亿美元的股权价值收购Dynavax。Dynavax是一家疫苗公司,拥有成人乙型肝炎疫苗,并拥有一款具有差异化优势的带状疱疹候选疫苗。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:张俊 SF065

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10